Illumina announces strategic partnerships with AstraZeneca, Janssen and Sanofi
Illumina announced collaborative partnerships with leading pharmaceutical companies to develop a universal next-generation sequencing-based oncology test system. The system will be used for clinical trials of targeted cancer therapies with a goal of developing and commercializing a multi-gene panel. August 21, 2014